MitraClip® Registry
Study Details
Study Description
Brief Summary
Percutaneous mitral valve repair with the MitraClip® system has emerged as a therapeutic alternative to surgical valve repair (PMVR) in high risk patients.
The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PMVR with the MitraClip® system. This registry is an open-end observational study to assess the characteristics and outcomes patients with severe mitral regurgitation undergoing PMVR.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- Major cardiac adverse events [30 days]
increase in the 30-day risk of adverse events among patients receiving PMVR
Secondary Outcome Measures
- Mortality [1 year]
Proportion of patients who are alive at 1 year after receiving
Eligibility Criteria
Criteria
Inclusion Criteria:
-
severe mitral regurgitation
-
percutaneous mitral valve repair (PMVR) with the MitraClip® system
Exclusion Criteria:
-
< 18 years
-
Patients considered by the heart team to be unlikely to receive meaningful or durable clinical benefit from the procedure
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Heinrich Heine University Div. of Cardiology, Pulmonary Disease and Vasculae Medicine | Dusseldorf | Germany | 40225 |
Sponsors and Collaborators
- Klinik für Kardiologie, Pneumologie und Angiologie
Investigators
- Principal Investigator: Malte Kelm, MD, Division of Cardiology, Pulmonary Disease and Vascular Medicine
- Study Chair: Malte Kelm, MD, Division of Cardiology, Pulmonary Disease and Vascular Medicine
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- MitraClip® Registry